Curon Medical, Inc. engages in the development, manufacture, and marketing of radiofrequency generators and single-use disposable devices for the treatment of gastrointestinal disorders in the United States, Europe, South Africa, and the Middle East. Its principal products include Stretta System and Secca System. The Stretta System is used for the treatment of gastroesophageal reflux disease, which consists of a disposable catheter with needle electrodes, as well as Curon Control Module, a radiofrequency energy generator. The Secca System is a radiofrequency energy-based system for the treatment of bowel incontinence. Using this system, physicians deliver radiofrequency energy to the muscle of anal canal. The company sells its products to general surgeons, gastroenterologists, and colon and rectal surgeons in the United States and internationally through direct sales force, manufacturing representatives, and third-party distributors. Curon Medical was founded in 1997. It was formerly known as Conway-Stuart Medical, Inc. and changed its name to Curon Medical, Inc. in 2000. Curon Medical is headquartered in Fremont, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for CRNM